Analyst Price Targets — RBOT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 13, 2024 3:19 pm | Adam Maeder | Piper Sandler | $10.50 | $6.07 | StreetInsider | Vicarious Surgical inc. (RBOT) PT Lowered to $10.50 at Piper Sandler |
| July 18, 2022 10:07 am | — | BTIG | $7.00 | $3.50 | Benzinga | BTIG Maintains Buy on Vicarious Surgical, Lowers Price Target to $7 |
| May 10, 2022 6:29 am | — | Piper Sandler | $5.00 | $3.56 | Benzinga | Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $5 |
Latest News for RBOT
WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.
WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RBOT.
U.S. House Trading
No House trades found for RBOT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.